1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on February 22, 2025

3 Magnificent Growth Stocks to Buy Right Now
AZN

Motley Fool

7 hours ago

3 Magnificent Growth Stocks to Buy Right Now

AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds
AZN

Insider Monkey

2 days ago

AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds

FibroGen sells China unit to AstraZeneca for $160m
AZN

Pharmaceutical Technology

2 days ago

FibroGen sells China unit to AstraZeneca for $160m

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
AZN

Zacks

2 days ago

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
AZN

Zacks

2 days ago

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus

AZN

MT Newswires

2 days ago

FibroGen to Sell China Unit to AstraZeneca for $160 Million

Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4
AZN

Insider Monkey

2 days ago

Here’s Why AstraZeneca PLC (AZN) Traded Lower in Q4

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
AZN

Reuters

2 days ago

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal

AstraZeneca deepens China presence with FibroGen deal
AZN

BioPharma Dive

2 days ago

AstraZeneca deepens China presence with FibroGen deal

AZN

Thomson Reuters StreetEvents

2 days ago

Q4 2024 Ionis Pharmaceuticals Inc Earnings Call

AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
AZN

Simply Wall St.

2 days ago

AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop There
AZN

Simply Wall St.

4 days ago

AstraZeneca (LON:AZN) Is Posting Promising Earnings But The Good News Doesn’t Stop There

AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial
AZN

Clinical Trials Arena

5 days ago

AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial

AstraZeneca: IMFINZI improved event-free survival, OS across MIBC
AZN

TipRanks

7 days ago

AstraZeneca: IMFINZI improved event-free survival, OS across MIBC

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
AZN

Motley Fool

7 days ago

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

AZN

MT Newswires

8 days ago

AstraZeneca's Bladder Cancer Treatment Improves Survival in Phase 3 Trial

AZN

Business Wire

8 days ago

IMFINZI® (durvalumab) perioperative regimen improved event-free survival and overall survival across muscle-invasive bladder cancer patients regardless of complete pathology response status in post-hoc exploratory analysis of NIAGARA Phase III trial

Is AstraZeneca PLC (AZN) the Best Foreign Dividend Stock to Buy According to Analysts?
AZN

Insider Monkey

8 days ago

Is AstraZeneca PLC (AZN) the Best Foreign Dividend Stock to Buy According to Analysts?

AZN

MT Newswires

10 days ago

AstraZeneca Seen Posting Double-Digit Earnings Growth in 2025, Morgan Stanley Says

3 UK Stocks That May Be Undervalued Based On Current Estimates
AZN

Simply Wall St.

10 days ago

3 UK Stocks That May Be Undervalued Based On Current Estimates

AstraZeneca PLC (AZN): Among the Best International Dividend Stocks to Buy Now
AZN

Insider Monkey

10 days ago

AstraZeneca PLC (AZN): Among the Best International Dividend Stocks to Buy Now

Is AstraZeneca PLC (AZN) the Safest Dividend Stock in the UK?
AZN

Insider Monkey

11 days ago

Is AstraZeneca PLC (AZN) the Safest Dividend Stock in the UK?

AZN

Morningstar Research

12 days ago

Analyst Report: AstraZeneca PLC

AZN

Argus Research

12 days ago

Weekly Stock List

AstraZeneca (LON:AZN) Is Increasing Its Dividend To $1.68
AZN

Simply Wall St.

13 days ago

AstraZeneca (LON:AZN) Is Increasing Its Dividend To $1.68

Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
AZN

Zacks

15 days ago

Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update

AstraZeneca PLC (AZN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
AZN

GuruFocus.com

15 days ago

AstraZeneca PLC (AZN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges

AZN

Morningstar Research

16 days ago

Analyst Report: AstraZeneca PLC

Why AstraZeneca Topped the Market on Thursday
AZN

Motley Fool

16 days ago

Why AstraZeneca Topped the Market on Thursday

AstraZeneca’s shares rise as it addresses China investigation
AZN

Pharmaceutical Technology

16 days ago

AstraZeneca’s shares rise as it addresses China investigation

Pound plunges as Bank of England cuts rates – and hints at more to come
AZN

The Telegraph

16 days ago

Pound plunges as Bank of England cuts rates – and hints at more to come

AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
AZN

Motley Fool

16 days ago

AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript

AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
AZN

Clinical Trials Arena

16 days ago

AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial

AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update
AZN

Zacks

16 days ago

AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update

AstraZeneca boss denies falling out with Labour despite scrapping £450m factory
AZN

The Telegraph

16 days ago

AstraZeneca boss denies falling out with Labour despite scrapping £450m factory

AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance
AZN

Investor's Business Daily

16 days ago

AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance

AZN

MT Newswires

16 days ago

Sector Update: Health Care

AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China
AZN

Benzinga

16 days ago

AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China

AstraZeneca’s Full Year and Q4 2024 results
AZN

Business Wire

16 days ago

AstraZeneca’s Full Year and Q4 2024 results

AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China
AZN

The Wall Street Journal

16 days ago

AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China

AZN

Associated Press Finance

16 days ago

Astrazeneca: Q4 Earnings Snapshot

AZN

MT Newswires

16 days ago

AstraZeneca's Q4 Earnings, Revenue Increase; Issues 2025 Outlook

CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi
AZN

Zacks

18 days ago

CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval
AZN

Pharmaceutical Technology

18 days ago

AstraZeneca lung cancer therapy Imfinzi recommended for EU approval

AZN

MT Newswires

19 days ago

European Equities Fall in Monday Trading; Euro Area Inflation Edges Higher

Seeking Clues to Astrazeneca (AZN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
AZN

Zacks

19 days ago

Seeking Clues to Astrazeneca (AZN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

AZN

MT Newswires

19 days ago

Market Chatter: Astrazeneca Rejects Revised UK Government Support to Build Vaccine Plant in England

AZN

MT Newswires

19 days ago

AstraZeneca Small Cell Lung Cancer Treatment Gets EU Recommendation as Monotherapy

AstraZeneca Stock Rally Will be Tested by Answers on China Probe
AZN

Bloomberg

19 days ago

AstraZeneca Stock Rally Will be Tested by Answers on China Probe

AstraZeneca abandons £450m vaccine factory in blow to Reeves
AZN

The Telegraph

22 days ago

AstraZeneca abandons £450m vaccine factory in blow to Reeves

AZN

MT Newswires

22 days ago

Sector Update: Health Care Stocks Fall Friday

AZN

MT Newswires

22 days ago

Sector Update: Health Care Stocks Higher Friday Afternoon

AZN

Associated Press Finance

22 days ago

AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government

AZN

MT Newswires

22 days ago

AstraZeneca Cancels Plan for $558 Million Investment in UK Vaccine Manufacturing Plant

AZN

MT Newswires

22 days ago

AstraZeneca, Daiichi Sankyo's Datopotamab Deruxtecan Recommended for Approval in EU to Treat Breast Cancer

Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & More
AZN

Zacks

22 days ago

Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & More

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
AZN

Zacks

24 days ago

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts

FDA expands Enhertu approval to include HER2-ultralow breast cancer patients
AZN

Pharmaceutical Technology

24 days ago

FDA expands Enhertu approval to include HER2-ultralow breast cancer patients

Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings?
AZN

Zacks

24 days ago

Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings?

Here's Why Astrazeneca (AZN) is a Strong Value Stock
AZN

Zacks

24 days ago

Here's Why Astrazeneca (AZN) is a Strong Value Stock

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication
AZN

Zacks

25 days ago

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

AZN

MT Newswires

25 days ago

AstraZeneca, Daiichi Sankyo's Enhertu Gets US FDA Approval for Treatment of Inoperable Breast Cancers

Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
AZN

BioPharma Dive

25 days ago

Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
AZN

Business Wire

a month ago

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug
AZN

Zacks

a month ago

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable
AZN

Barrons.com

a month ago

Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barron’s Roundtable

Here's Why Astrazeneca (AZN) is a Strong Growth Stock
AZN

Zacks

a month ago

Here's Why Astrazeneca (AZN) is a Strong Growth Stock

Mixed results for Keytruda; AbbVie to work with Neomorph
AZN

BioPharma Dive

a month ago

Mixed results for Keytruda; AbbVie to work with Neomorph

AZN

MT Newswires

a month ago

Astrazeneca to Invest $570 Million in Canadian Operations

AZN

MT Newswires

a month ago

AstraZeneca Plans $820 Million Investment in Canada

AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
AZN

CNW Group

a month ago

AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025?
AZN

Insider Monkey

a month ago

Why Is AstraZeneca PLC (AZN) Among the Best Large-Cap Value Stocks to Buy in 2025?

AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi
AZN

Pharmaceutical Technology

a month ago

AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients
AZN

Benzinga

a month ago

FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients

J&J’s Lazcluze/Rybrevant combination obtains European approval to treat NSCLC
AZN

Pharmaceutical Technology

a month ago

J&J’s Lazcluze/Rybrevant combination obtains European approval to treat NSCLC

J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC
AZN

Pharmaceutical Technology

a month ago

J&Js Lazcluze/Rybrevant combination obtains European approval to treat NSCLC

AZN

MT Newswires

a month ago

AstraZeneca, Daiichi Sankyo's Datroway Gets US FDA Approval for Advanced Breast Cancer Treatment

AstraZeneca, Daiichi’s Enhertu successor gets first FDA OK in breast cancer
AZN

BioPharma Dive

a month ago

AstraZeneca, Daiichi’s Enhertu successor gets first FDA OK in breast cancer

AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer
AZN

Zacks

a month ago

AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AZN

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

FDA Approves Two Breakthrough Cancer Treatments for AstraZeneca
AZN

GuruFocus.com

a month ago

FDA Approves Two Breakthrough Cancer Treatments for AstraZeneca

AstraZeneca secures first BTK approval in first-line mantle cell lymphoma
AZN

Pharmaceutical Technology

a month ago

AstraZeneca secures first BTK approval in first-line mantle cell lymphoma

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
AZN

Yahoo Finance

a month ago

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
AZN

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
AZN

Business Wire

a month ago

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer

Medicare to negotiate prices on 15 drugs, including Ozempic
AZN

Yahoo Finance Video

a month ago

Medicare to negotiate prices on 15 drugs, including Ozempic

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales
AZN

Zacks

a month ago

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
AZN

Yahoo Finance

a month ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

AZN

Financial Times

a month ago

AstraZeneca overhauls management of its scandal-hit China division

AZN

MT Newswires

a month ago

Astrazeneca Says Mantle Cell Lymphoma Combination Treatment Receives FDA Approval

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma
AZN

Business Wire

a month ago

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma

COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
AZN

Pharmaceutical Technology

a month ago

COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth

AZN

MT Newswires

a month ago

Cellectis Files for Resale of 44 Million Company Shares by AstraZeneca

JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead
AZN

Pharmaceutical Technology

a month ago

JP Morgan 2025: AstraZeneca promises a ‘catalyst-rich’ year ahead

3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices
AZN

Motley Fool

a month ago

3 High-Yielding Dividend Stocks That Are Trading at Dirt Cheap Prices

Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros’ Portfolio?
AZN

Insider Monkey

a month ago

Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros’ Portfolio?

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
AZN

Zacks

a month ago

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term

AZN

MT Newswires

a month ago

Astrazeneca Receives Priority Review for Datopotamab Deruxtecan in Non-Small Cell Lung Cancer

Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
AZN

Business Wire

a month ago

Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

3 Cheap Growth Stocks to Buy in 2025
AZN

Motley Fool

a month ago

3 Cheap Growth Stocks to Buy in 2025

Share on Social Networks: